Wuhan, China

Fanqi Qu

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fanqi Qu. Retrieved from https://idiyas.com/inventor/fanqi-qu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Therapeutics by Fanqi Qu

Introduction

Fanqi Qu is an accomplished inventor based in Wuhan, China. He has made significant contributions to the field of therapeutics, particularly in the development of novel compounds for cancer treatment. His work exemplifies the intersection of scientific research and practical application in medicine.

Latest Patents

Fanqi Qu holds a patent for "Triazole derivatives, their preparation and their application in therapeutics." This invention relates to novel compounds of a specific formula, which are designed to be used in therapeutic applications, especially in the treatment of cancers. The patent outlines the processes for preparing these compounds and their potential compositions.

Career Highlights

Throughout his career, Fanqi Qu has worked with prestigious research institutions, including the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to contribute to significant advancements in medical research.

Collaborations

Fanqi Qu has collaborated with notable colleagues, including Ling Peng and Palma Rocchi. These partnerships have further enriched his research and development efforts in the field of therapeutics.

Conclusion

Fanqi Qu's innovative work in developing triazole derivatives showcases his commitment to advancing therapeutic options for cancer treatment. His contributions to the field highlight the importance of research and collaboration in driving medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…